Criticaleye recently caught up with Abbas Hussain, President, Emerging Markets at GlaxoSmithKline, to discuss the state of emerging markets and the initial stages of GSK’s low-cost drug plan, a revolutionary scheme set to change the face of the pharmaceutical industry.
Read, watch & listen to some of the latest thought leadership from our Community.
Europe’s productivity challenge is growing and the clear root cause is underinvestment in technology. In this report, Criticaleye Partner Accenture explores the potential of artificial intelligence (AI) to bo...
How are women leaders responding to disruption in today’s uncertain world? This report from Criticaleye Partner AlixPartners draws on insights from its latest Disruption Index to reveal that women in leadership ar...
This research, conducted at our CEO Retreat, subtitled When Leadership Goes Faster, provides a fascinating insight into the challenges and priorities for CEOs this year. Key findings from Criticaleye's CEO Resear...
Displaying 1 to 3 of 393
 (002).png "Palo Alto Networks"){kind=logo}
We use cookies to improve your experience. By using our site, you agree to our use of cookies.
